MedTrace Logo

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth

NCT02458781 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2015-06-01

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal bacterial overgrowth (SIBO).

Conditions

  • Small Intestinal Bacterial Overgrowth

Interventions

DRUG

Metronidazole

Metronidazole 500mg given twice daily for 14 days

DRUG

Ciprofloxacin

Ciprofloxacin 500mg given twice daily for 14 days

DRUG

Placebo

Placebo given twice daily for 14 days

Sponsors & Collaborators

  • San Antonio Military Medical Center

    lead FED

Principal Investigators

  • Karin S Gilkison, MD, MPH · Gastroenterology Fellow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-01-31
Completion
2018-06-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02458781 on ClinicalTrials.gov